Abstract: Peripheral neuropathy due to alcohol abuse is common but often difficult to identify in its initial
I. Introduction
Peripheral neuropathy is the most frequent neurological complication occurring from chronic alcohol abuse. It affects 10-75% of people with alcoholic abuse. [1] The relative risk of peripheral polyneuropathy in patients with chronic alcohol abuse is 3.9%. [2] It is characterized by a symmetric polyneuropathy involving the lower extremities with little response to recommended treatment. [3, 4] Various factors precipitate alcohol associated neuropathy; these include direct toxicity of alcohol, underlying malnourishment, quantity and duration of alcohol consumption, as well as a familial predisposition. [3] Peripheral neuropathy due to alcoholism is difficult to diagnose clinically in the initial stages. Peripheral nerves have a limited capacity to regenerate, emphasizing the importance of early detection of this disease. [5] This study utilizes Toronto Clinical Neuropathy Scoring Scale (TCNS) to identify neuropathy and grade its severity among patients with alcohol dependence syndrome. [6] II.
Materials and methods
Materials:
A total of 30 patients admitted at a tertiary hospital in Southern India with history suggestive of Alcohol Dependence Syndrome were included in this study. The descriptive study was performed over a period of 6 months, starting from January 2016.
Inclusion criteria:
Patients who consumed at least 100 ml of ethyl alcohol (3 L of beer or 300 ml of spirits) per day for more than 3 years were recruited for the study. [7] 2.3 Exclusion criteria: Those patients with h/o diabetes mellitus, occupational exposure to toxins and vibrations, underlying malignancy or receiving chemotherapy, significant trauma to limbs, chronic kidney disease, hypothyroidism or fever, leprosy, shingles or HIV at presentation were excluded.
Methods:
The study utilized the Toronto Clinical Neuropathy Scoring Scale (TCNS) to identify the presence of alcohol related peripheral neuropathy in the patients. The TCNS is a validated tool that has been found to correlate to nerve conduction studies as well as to nerve biopsy findings in patients with diabetic polyneuropathy. [6] The maximum score in TCNS is 19, derived from clinical assessment of symptoms, sensory tests, and lower limb reflexes. Six scores resulted from recognizing sensory symptoms. They included identifying presence of pain, numbness, tingling and weakness in the foot, presence of similar upper-limb symptom and ataxia. Five points were derived from sensory testing and eight from lower-limb reflexes. Sensory testing was done at great toe for pinprick, temperature, light touch, vibration and position. The reflexes were [8] In addition, patients were screened using the CAGE questionnaire which is a validated tool to identify the presence of alcohol dependence. Developed by Ewing in 1968, the screening test has 4 items, and a score greater than 2 is considered clinically significant. [9, 10] The amount of alcohol consumption could correlate with the severity of neuropathy. The total life time dose of ethanol (TLDE) expressed in kg of ethanol per kg of body weight, was utilized to identify the same.
Statistical data analysis was carried out using SPSS 8 software. A p-value between 0.01 and 0.05 was set as statistically significant and p-value less than 0.01 was considered to be highly significant.
III. Results
The prevalence of neuropathy in the present study was 63.3% (n=19). Among the 19 patients with neuropathy, 7 were detected to have mild neuropathy, 4 with moderate neuropathy and 8 with severe neuropathy. The spectrum of alcoholic neuropathy observed in the present study is depicted in The details of study population with and without neuropathy are compared in Table 1 . The patients with alcohol dependence included in our study were aged between 30-55 years. The average age in the groups without neuropathy and with neuropathy were similar, with the mean ages of 39.9 ± 7.5 and 39.5 ± 17.4 years respectively. A higher incidence of family history of alcoholism was noted in subjects with neuropathy. Table 1 : Demography of patients with and without neuropathy Table 2 compares average years of alcohol consumption, TLDE and CAGE score among patients with and without neuropathy. The mean alcohol consumption years were 17.0 ± 6.7 in subjects without neuropathy. This was similar to those having neuropathy with a mean consumption of 17.4 ± 6.7 years. The mean value of TLDE was 19.2 ± 8.8 in those without neuropathy and 27.1 ± 17.1 in patients of alcoholic neuropathy. The pvalue calculated using Mann-Whitney test did not show statistically significant relation between the TLDE and the occurrence of peripheral neuropathy in this study group. In response to CAGE questionnaire, patients without neuropathy scored 3.18 ± 0.60, while those with clinically demonstrable neuropathy scored 3.68 ± 0.48. This was statistically significant between patients with and without neuropathy (p < 0.05).
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Mean alcoholic intake duration (years) 17.0 ± 6.7
17. The mean value of overall TCNS score of subjects without neuropathy was 2.91 ± 1.64. This included scores from clinical symptoms, sensory tests and reflexes. It was correspondingly 9.84 ± 3.17 on patients with neuropathy. Further, the clinical symptoms and sensory signs scores as obtained through TCNS were analysed. On a scale of 6, the mean scores on clinical symptoms in patients with and without neuropathy were 3.05 ± 1.96 and 1.09 ± 0.94, respectively. The signs score was derived on a scale of 5. The mean score on sensory signs in patients with and without neuropathy were 2.32 ± 1.38 and 1.82 ± 0.98.
The variation of clinical symptoms and sensory signs were compared among people with different grades of neuropathy. The mean symptoms score for patients with mild, moderate and severe neuropathy were 3.14 ± 1.46, 0.75 ± 0.96 and 4.12 ± 1.81, respectively. The corresponding mean values of signs score for patients with mild, moderate and severe neuropathy were 1.86 ± 0.90, 1.0 ± 0.82 and 3.37 ± 1.19. In some patients, clinical symptoms were more prominent than sensory signs, whereas in others symptoms and signs were comparatively present in equal or lesser grades This was expressed as the percentage of patients having clinical symptoms score greater, equal or less than sensory signs score, as illustrated in Table 3 . From the above table, we conclude that those patients who had mild neuropathy have more symptoms while they have hardly any sensory signs or deficits. In moderate and severe neuropathy, the patients tend to have more clinically detectable signs than symptoms.
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IV. Discussion
Early identification of alcohol induced peripheral neuropathy caused by chronic alcoholism and timely initiation of its treatment are of utmost importance to prevent chronic disabilities to the patient. Therefore, awareness of physicians has a key role to play in detecting peripheral neuropathy.
Our study identified the prevalence of alcoholic neuropathy to be 63.3%. This was similar to the findings of Ammendola et al. [11] reporting an occurrence of 67.7%. However, in another study, they noticed that the frequency of alcoholic neuropathy was only 30.3%. [12] Strong family history of alcoholism was observed in patients with alcoholic neuropathy as compared to those without neuropathy. While 78.9% of patients with neuropathy reported positive family history of alcoholism, it was correspondingly 45.4% in the group without neuropathy. This is similar to the findings of Ammendola et al. [12] where 36% of patients without neuropathy had a positive family association of alcoholism and 51% in patients with neuropathy. Pessione et al. [13] also reported similar observations and suggested that alcohol induced neuropathy may be a marker of hereditary susceptibility to alcoholism.
There are conflicting reports on the role of nutritional deficiency and toxic effect of alcohol in initiating peripheral neuropathy on alcohol dependents. Shattuck proposed that lack of thiamine played an important role in developing neuropathy. [14] Strauss conducted a study on ten patients who continued their daily alcohol consumption along with a well-balanced diet supplemented by yeast and vitamin B concentrates. He concluded that alcoholic neuropathy resulted from dietary deficiency and not from the neurotoxic effects of alcohol. [15] Victor and Adams presented further evidences supporting that alcoholic neuropathy is fundamentally a nutritional disease. [16] On the contrary, Behse and Buchthal reported no relation between nutritional status and neuropathy. [7] Monforte et al. [17] identified that total life time of amount of alcohol and duration of alcohol consumption correlated with neuropathy.
[ Studies by Ammandola et al. [12] and Mellion et al. [18] established significant association between duration of alcohol consumption and cumulative alcohol intake (TLDE) to neuropathy. In the present study, the average duration of alcohol consumption was 17.3 ± 6.6 years. The mean total life time dose of alcohol was 24.23 ± 15.0. There was no significant difference noted between the groups with and without neuropathy on the basis of total life time dose of ethanol or average alcohol consumption years. This suggests that the toxic dose of alcohol may not be the only factor contributing to alcoholic peripheral neuropathy.
The most frequent symptom, foot pain was seen in 47% of the study population. Other common symptoms included numbness and tingling sensation were noted in 43%. The most commonly detected sign on neurological examination was loss of light touch sensation and was noted in 73% of the study population. This was followed by loss of vibration sense, observed in 60% of subjects. The prevalence of clinical symptoms and sensory signs among different grades of neuropathy were assessed based on their respective scores derived from TCNS. In the present study, 71.4% of patients detected with mild neuropathy had more presenting symptoms than deficits in the sensory system. In patients with moderate neuropathy, sensory signs were more detectable than clinical symptoms and 75% of them had more sensory signs than symptoms. However, patients with severe neuropathy presented positive symptoms and sensory signs equally. We felt that sensory symptoms are more consistent than signs for diagnosis of alcoholic neuropathy in initial stages. There was only one female enrolled in this study. She had presented with 5 years of alcohol abuse. She developed moderate neuropathy despite comparatively fewer years of alcohol abuse and low LTDE as compared to males. This also correlates with the findings of Ammendola et al. [11] where females demonstrated lower tolerance to toxic levels of alcohol.
As noted from the study, majority of alcohol dependent patients presented with symptoms of peripheral neuropathy. In patients with severe neuropathy, symptoms, sensory and reflex mechanisms were affected. Along with the duration and quantity of alcohol consumed there may be other modulating factors that lead to neuropathy in alcohol dependent patients. Possible limitations of the study are relatively small sample size and lack of nerve conduction studies. Further studies are recommended to evaluate the effect of nutritional status, genetic predisposition and other factors in perpetuation of peripheral neuropathy in patients with chronic alcohol abuse.
V. Conclusion
Peripheral neuropathy is a major complication of alcohol abuse. TCNS is a simple, cost effective and efficient method to ascertain the presence of alcoholic neuropathy and grade its severity. Sensory symptoms, sensory deficits and diminished reflexes are seen in patients with alcoholic neuropathy. Studies on larger population groups are recommended for better understanding of the pattern of peripheral neuropathy. 
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